Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Robert Janknegt"'
Publikováno v:
Therapeutic Advances in Urology, Vol 10 (2018)
Background: Androgen deprivation therapy (ADT) with luteinizing hormone-releasing hormone (LHRH) agonists is well established for the treatment of men with metastatic prostate cancer. As clear differences in efficacy, safety, or tolerability between
Externí odkaz:
https://doaj.org/article/a0b0fdfdce564c538007b71111893ffa
Publikováno v:
Acta Scientific Pharmaceutical Sciences. 5:91-112
Publikováno v:
Acta Scientific Pharmaceutical Sciences. 4:145-175
Publikováno v:
Acta Scientific Pharmaceutical Sciences. 4:95-119
Publikováno v:
Acta Scientific Pharmaceutical Sciences. 4:73-94
Publikováno v:
European Journal of Hospital Pharmacy: Science and Practice, 28(2):e4. BMJ PUBLISHING GROUP
European Journal of Hospital Pharmacy-Science and Practice, 28, 2
European Journal of Hospital Pharmacy-Science and Practice, 28
Eur J Hosp Pharm
European Journal of Hospital Pharmacy-Science and Practice, 28, 2
European Journal of Hospital Pharmacy-Science and Practice, 28
Eur J Hosp Pharm
ObjectivesThe large number of available medicines and devices makes it almost impossible to have sufficient knowledge of each individual medicine and device, especially for general practitioners. This may lead to suboptimal treatment, more exacerbati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cbd13270e41a2f9dcb5472addcd709e
https://doi.org/10.1136/ejhpharm-2020-002229
https://doi.org/10.1136/ejhpharm-2020-002229
Publikováno v:
Therapeutic Advances in Urology, Vol 10 (2018)
Background: Androgen deprivation therapy (ADT) with luteinizing hormone-releasing hormone (LHRH) agonists is well established for the treatment of men with metastatic prostate cancer. As clear differences in efficacy, safety, or tolerability between
Publikováno v:
Generics and Biosimilars Initiative Journal. 3:133-142
Autor:
Robert Janknegt
Publikováno v:
Generics and Biosimilars Initiative Journal. 1:42-45
The increased use of generic medicines is one of the mostimportant elements in terms of the creation and maintenance ofsustainable healthcare systems in Europe. Generic medicineprescribing by physicians in European countries has been sup -ported by a
Publikováno v:
Expert Opinion on Pharmacotherapy, 13(3), 357-385. Informa Healthcare
InforMatrix is an interactive matrix model, in which pharmacotherapeutic strategies are supported in a rational manner, by means of a transparent selection methodology.In this paper, InforMatrix is applied to ADP antagonists, including clopidogrel, p